Company Filing History:
Years Active: 2011
Title: Chouhei Sakakura: Innovator in Cancer Detection
Introduction
Chouhei Sakakura is a prominent inventor based in Kyoto, Japan. He has made significant contributions to the field of medical technology, particularly in the detection of metastatic cancer cells. His innovative approach has the potential to improve patient outcomes in gastric cancer treatment.
Latest Patents
Sakakura holds a patent for a method of detecting metastasizing cancer cells originating in stomach cancer. This method involves collecting a biological sample from a subject and detecting the presence of either aldehyde dehydrogenase or dopa decarboxylase in the sample. The presence of these markers indicates a high possibility of metastatic cancer cells originating from gastric cancer. This rapid and reliable detection method is crucial for determining the need for intraperitoneal cancer chemotherapy.
Career Highlights
Chouhei Sakakura is associated with Riken Corporation, where he has been able to apply his research and innovations in a practical setting. His work has garnered attention for its potential impact on cancer diagnostics and treatment strategies.
Collaborations
Sakakura has collaborated with notable colleagues, including Yoshihide Hayashizaki and Yasushi Okazaki. These partnerships have contributed to the advancement of research in cancer detection and treatment methodologies.
Conclusion
Chouhei Sakakura's contributions to cancer detection represent a significant advancement in medical technology. His innovative methods have the potential to enhance the accuracy of cancer diagnostics and improve treatment decisions for gastric cancer patients.